Library

Displaying 2,326 - 2,350 of 2,711

Post Graduate Year II Oncology Residency Training; the South Florida Before, After, and Future Journey
Post Graduate Year II Oncology Residency Training; the South Florida Before, After, and Future Journey
By: Frank Gentile, PharmD, BCOP & Shreya Shah, PharmD, BCOP, & Jessica Unzaga, PharmD, BCOP
Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics
Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics
By: Halena Leah Marcelin, PharmD, MS & Courtney Zephir, MBA
Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics
Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics
By: Halena Leah Marcelin, PharmD, MS & Courtney Zephir, MBA
Oncology Pharmacy Operations Efficiency Journey
Oncology Pharmacy Operations Efficiency Journey
By: Jessica Lemoine, PharmD, MS & Ernesto Perez, PharmD
Oncology Pharmacy Operations Efficiency Journey
Oncology Pharmacy Operations Efficiency Journey
By: Jessica Lemoine, PharmD, MS & Ernesto Perez, PharmD
CAR-T Cells: Learning How to Deal with Complications
CAR-T Cells: Learning How to Deal with Complications
By: Jessica Unzaga, PharmD, BCPS, BCOP
Access to Biosimilars and New Indications
Access to Biosimilars and New Indications
By: Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
Biosimilars as Front-Line Options for Cancer Care
Biosimilars as Front-Line Options for Cancer Care
By: Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
Integration of Biosimilars in Oncology Care
Integration of Biosimilars in Oncology Care
By: Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Biosimilars as Front Line Options for Cancer Care
Biosimilars as Front Line Options for Cancer Care
By: Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Biosimilars, Beyond the Scientific Review
Biosimilars, Beyond the Scientific Review
By: Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Biosimilars as Front-Line Options for Cancer Care
Biosimilars as Front-Line Options for Cancer Care
By: Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Drug Brown and White Bagging: What is It and Where Does it Lead Us?
Drug Brown and White Bagging: What is It and Where Does it Lead Us?
By: Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Integration of Biosimilars in Oncology Care
Integration of Biosimilars in Oncology Care
By: Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Drug Brown and White Bagging: What is It and Where Does it Lead Us?
Drug Brown and White Bagging: What is It and Where Does it Lead Us?
By: Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Payor Benefits Design Changing Oncology Care Delivery
Payor Benefits Design Changing Oncology Care Delivery
By: Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE